NYSE:HUM - Humana Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $470.22
Forecasted Upside: 12.18 %
Number of Analysts: 14
Breakdown:
0 Sell Ratings
4 Hold Ratings
10 Buy Ratings
0 Strong Buy Ratings

^$419.18 As of 06/11/2021 01:00 AM ET

▼ -1.78 (-0.42%)

1 month | 3 months | 12 months

Get New Humana Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for HUM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HUM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$470.22

▲ +12.18% Upside Potential

This price target is based on 14 analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $470.22, with a high forecast of $510.00 and a low forecast of $410.00. The average price target represents a 12.18% upside from the last price of $419.18.

Buy

The current consensus among 14 contributing investment analysts is to buy stock in Humana. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
11 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

12/21/2019

0 strong buy ratings
12 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

3/20/2020

0 strong buy ratings
13 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

6/18/2020

0 strong buy ratings
15 buy ratings
6 hold ratings
0 sell ratings

Ratings as of

9/16/2020

0 strong buy ratings
14 buy ratings
5 hold ratings
0 sell ratings

Ratings as of

12/15/2020

0 strong buy ratings
14 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

3/15/2021

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

5/14/2021

0 strong buy ratings
10 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

6/13/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
5/24/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$472.00	N/A	i
5/18/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$472.00	Medium	i
4/29/2021	Citigroup	Boost Price Target		$496.00 ➝ $510.00	Low	i
4/29/2021	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Boost Price Target	Buy	$496.00 ➝ $510.00	Low	i
4/29/2021	Oppenheimer	Boost Price Target	Outperform	$460.00 ➝ $480.00	Low	i
4/29/2021	Mizuho	Boost Price Target	Buy	$462.00 ➝ $480.00	Medium	i
1/6/2021	Argus	Boost Price Target	Buy	$430.00 ➝ $450.00	N/A	i
1/4/2021	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$429.00 ➝ $479.00	N/A	i
11/30/2020	SVB Leerink	Lower Price Target	Sell ➝ Outperform	$505.00 ➝ $500.00	High	i Rating by D. Ha at SVB Leerink LLC
11/4/2020	Smith Barney Citigroup	Boost Price Target		$469.00 ➝ $496.00	Low	i
11/4/2020	Credit Suisse Group	Boost Price Target	Outperform	$423.00 ➝ $465.00	Low	i
11/4/2020	Oppenheimer	Boost Price Target	Outperform	$440.00 ➝ $460.00	Low	i
11/4/2020	Stephens	Boost Price Target	Overweight	$450.00 ➝ $490.00	Low	i
10/13/2020	Truist	Boost Price Target		$455.00 ➝ $475.00	Low	i
10/1/2020	Sanford C. Bernstein	Initiated Coverage	Market Perform	$459.00	Medium	i
10/1/2020	Piper Sandler	Boost Price Target	Overweight	$473.00 ➝ $495.00	Low	i
9/10/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$397.00 ➝ $431.00	High	i
8/18/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$394.00 ➝ $452.00	Low	i
8/17/2020	Royal Bank of Canada	Boost Price Target	Sector Perform	$388.00 ➝ $420.00	Low	i
8/10/2020	Stephens	Boost Price Target	Overweight	$433.00 ➝ $450.00	Low	i
8/7/2020	Mizuho	Boost Price Target	Buy	$420.00 ➝ $462.00	High	i Rating by Ann Hynes at Mizuho
8/6/2020	Credit Suisse Group	Reiterated Rating	Buy		Low	i
8/6/2020	Piper Sandler	Boost Price Target	Overweight	$442.00 ➝ $473.00	Medium	i
8/6/2020	Oppenheimer	Boost Price Target	Outperform	$425.00 ➝ $440.00	Low	i
8/6/2020	SVB Leerink	Boost Price Target	Outperform	$465.00 ➝ $496.00	Medium	i Rating by D. Ha at SVB Leerink LLC
7/1/2020	SVB Leerink	Initiated Coverage	Outperform	$465.00	Low	i Rating by S. Davis at SVB Leerink LLC
6/18/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$421.00 ➝ $397.00	Low	i
6/17/2020	Cantor Fitzgerald	Boost Price Target		$405.00 ➝ $410.00	Medium	i
6/16/2020	Cowen	Reiterated Rating	Outperform ➝ Market Perform	$410.00	Medium	i
6/5/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$510.00	Medium	i Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
5/21/2020	SunTrust Banks	Boost Price Target	Hold	$400.00 ➝ $440.00	Low	i Rating by David S Macdonald at SunTrust Banks, Inc.
5/4/2020	Mizuho	Boost Price Target	Buy	$405.00 ➝ $420.00	Low	i Rating by Ann Hynes at Mizuho
4/30/2020	CSFB	Boost Price Target	Outperform	$400.00 ➝ $423.00	Medium	i
4/30/2020	Credit Suisse Group	Boost Price Target	Outperform	$400.00 ➝ $423.00	High	i
4/30/2020	Citigroup	Boost Price Target	Buy	$424.00 ➝ $435.00	Medium	i
4/30/2020	Morgan Stanley	Boost Price Target	Overweight	$375.00 ➝ $500.00	Medium	i
4/30/2020	Oppenheimer	Boost Price Target	Outperform	$400.00 ➝ $425.00	Medium	i
4/13/2020	Morgan Stanley	Boost Price Target	Overweight	$343.00 ➝ $375.00	Medium	i
3/29/2020	Barclays	Reiterated Rating	Buy		High	i
3/27/2020	Morgan Stanley	Lower Price Target	Overweight	$460.00 ➝ $343.00	Medium	i
2/19/2020	Royal Bank of Canada	Reiterated Rating	Hold	$370.00	Low	i
2/18/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$363.00 ➝ $433.00	Medium	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
2/14/2020	Mizuho	Reiterated Rating	Buy	$405.00	N/A	i Rating by Ann Hynes at Mizuho
2/6/2020	Morgan Stanley	Boost Price Target	Overweight	$457.00 ➝ $460.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
2/6/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$319.00 ➝ $363.00	Medium	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
2/6/2020	Mizuho	Boost Price Target	Buy	$400.00 ➝ $405.00	Medium	i
2/5/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$345.00 ➝ $400.00	Low	i Rating by S. Halper at Cantor Fitzgerald
1/27/2020	The Goldman Sachs Group	Reiterated Rating	Buy	$425.00	Medium	i Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
1/23/2020	UBS Group	Boost Price Target	Neutral	$321.00 ➝ $406.00	Low	i
1/8/2020	Credit Suisse Group	Boost Price Target	Outperform	$378.00 ➝ $400.00	High	i
1/3/2020	JPMorgan Chase & Co.	Boost Price Target	Overweight	$437.00 ➝ $448.00	Medium	i
1/3/2020	The Goldman Sachs Group	Reiterated Rating	Buy ➝ Buy	$425.00 ➝ $425.00	Medium	i
12/20/2019	JPMorgan Chase & Co.	Boost Price Target	Overweight	$322.00 ➝ $437.00	Low	i
12/17/2019	SunTrust Banks	Reiterated Rating	Hold	$370.00	Low	i Rating by David S Macdonald at SunTrust Banks, Inc.
12/11/2019	Wells Fargo & Company	Reiterated Rating	Overweight	$338.00 ➝ $400.00	Low	i
12/6/2019	Barclays	Boost Price Target	Overweight	$327.00 ➝ $358.00	Low	i
11/20/2019	Argus	Boost Price Target	Buy	$370.00	Low	i
11/18/2019	Morgan Stanley	Reiterated Rating	Buy	$337.00 ➝ $360.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
11/15/2019	SunTrust Banks	Boost Price Target	Positive ➝ Hold	$350.00	High	i
11/7/2019	SunTrust Banks	Boost Price Target	Hold	$335.00	High	i
10/17/2019	Mizuho	Initiated Coverage	Buy	$316.00	High	i
9/30/2019	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$345.00 ➝ $290.00	Low	i
9/26/2019	Morgan Stanley	Lower Price Target	Overweight	$342.00 ➝ $337.00	High	i Rating by Ricky Goldwasser at Morgan Stanley
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$300.00	High	i
8/23/2019	Morgan Stanley	Boost Price Target	Overweight	$315.00 ➝ $342.00	Medium	i Rating by Ricky Goldwasser at Morgan Stanley
8/12/2019	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight	$300.00 ➝ $345.00	Medium	i Rating by S. Halper at Cantor Fitzgerald
8/1/2019	JPMorgan Chase & Co.	Boost Price Target	Overweight	$288.00 ➝ $322.00	Low	i
8/1/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$315.00 ➝ $341.00	Low	i
8/1/2019	UBS Group	Boost Price Target	Neutral	$266.00 ➝ $317.00	Low	i Rating by Whit Mayo at UBS Group AG
8/1/2019	SunTrust Banks	Boost Price Target	Hold	$340.00	Low	i
7/12/2019	Morgan Stanley	Lower Price Target	Overweight	$331.00 ➝ $315.00	High	i Rating by Zachary Sopcak at Morgan Stanley
5/2/2019	SunTrust Banks	Lower Price Target		$300.00	Low	i
5/2/2019	Oppenheimer	Lower Price Target	Outperform	$373.00 ➝ $350.00	Low	i
5/2/2019	Morgan Stanley	Set Price Target	Buy	$331.00	Low	i Rating by Zachary Sopcak at Morgan Stanley
5/2/2019	Credit Suisse Group	Lower Price Target	Outperform	$352.00 ➝ $315.00	Low	i
5/2/2019	Citigroup	Lower Price Target	Buy ➝ Buy	$362.00 ➝ $302.00	Low	i
4/23/2019	UBS Group	Initiated Coverage	Neutral ➝ Neutral	$266.00	Medium	i
4/17/2019	Barclays	Lower Price Target	Overweight ➝ Overweight	$351.00 ➝ $327.00	Low	i
2/7/2019	Citigroup	Lower Price Target	Buy ➝ Buy	$397.00 ➝ $362.00	Low	i
2/7/2019	Credit Suisse Group	Lower Price Target	Outperform	$390.00 ➝ $352.00	Low	i
1/14/2019	Stephens	Initiated Coverage	Overweight	$336.00	Low	i
1/11/2019	Cowen	Upgrade	Market Perform ➝ Outperform	$275.02	High	i
1/6/2019	Barclays	Reiterated Rating	Buy	$351.00	Low	i
1/2/2019	Cantor Fitzgerald	Reiterated Rating	Hold	$325.00	High	i
12/20/2018	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$283.00	Medium	i
11/8/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Buy	$400.00 ➝ $418.00	Low	i Rating by Zachary Sopcak at Morgan Stanley
11/8/2018	BMO Capital Markets	Set Price Target	Buy	$390.00	Low	i Rating by Matthew Borsch at BMO Capital Markets
11/8/2018	Royal Bank of Canada	Boost Price Target	Sector Perform ➝ Sector Perform	$318.00 ➝ $349.00	Low	i
11/8/2018	Credit Suisse Group	Boost Price Target	Outperform ➝ Outperform	$370.00 ➝ $390.00	Low	i
11/8/2018	Bank of America	Boost Price Target	Buy	$400.00 ➝ $415.00	Medium	i
11/8/2018	Jefferies Financial Group	Boost Price Target	Buy ➝ Buy	$388.00 ➝ $410.00	High	i
9/19/2018	SunTrust Banks	Boost Price Target	Hold	$380.00	Low	i
9/17/2018	Cowen	Initiated Coverage	Market Perform	$372.00	Low	i
9/13/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$370.00	Medium	i
9/4/2018	Credit Suisse Group	Boost Price Target	Outperform	$350.00 ➝ $370.00	Low	i
9/4/2018	Argus	Boost Price Target	Buy	$375.00	Low	i
8/24/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$355.00 ➝ $380.00	Low	i
8/2/2018	SunTrust Banks	Reiterated Rating	Hold	$350.00	Low	i
8/2/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$355.00	Low	i
8/2/2018	Bank of America	Boost Price Target	Buy ➝ Buy	$338.00 ➝ $375.00	Low	i
8/2/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Overweight	$362.00 ➝ $365.00	Low	i
8/2/2018	Jefferies Financial Group	Boost Price Target	Buy ➝ Buy	$356.00 ➝ $372.00	Low	i
8/2/2018	Royal Bank of Canada	Reiterated Rating	Hold	$318.00	Low	i
7/12/2018	Morgan Stanley	Initiated Coverage	Overweight	$362.00	Low	i
7/6/2018	Piper Jaffray Companies	Boost Price Target	Overweight	$326.00 ➝ $350.00	Medium	i
6/25/2018	BMO Capital Markets	Boost Price Target	Outperform ➝ Outperform	$328.00 ➝ $355.00	Low	i
6/1/2018	Citigroup	Reiterated Rating	Buy ➝ Buy	$280.00 ➝ $340.00	Low	i
5/3/2018	Oppenheimer	Boost Price Target	Outperform	$305.00 ➝ $311.00	Low	i
4/23/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$250.00	High	i
4/16/2018	Argus	Boost Price Target	Buy ➝ Buy	$270.00 ➝ $330.00	Low	i
4/4/2018	Piper Jaffray Companies	Reiterated Rating	Buy	$313.00	Low	i
2/12/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$253.00 ➝ $271.00	Low	i
2/9/2018	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold ➝ Hold	$259.00 ➝ $270.00	Low	i
2/8/2018	Oppenheimer	Boost Price Target	Outperform	$275.00 ➝ $305.00	Medium	i
2/8/2018	SVB Leerink	Boost Price Target	Outperform ➝ Outperform	$280.00 ➝ $300.00	High	i
2/8/2018	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$264.90 ➝ $246.00	Medium	i
2/7/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$250.00	Medium	i
1/12/2018	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$221.00	Medium	i
1/3/2018	The Goldman Sachs Group	Initiated Coverage	Buy ➝ Buy	$305.00	Low	i
12/13/2017	Cowen	Reiterated Rating	Buy	$285.00	Low	i
12/5/2017	Cantor Fitzgerald	Reiterated Rating	Hold	$230.00	Low	i Rating by S. Halper at Cantor Fitzgerald
11/10/2017	Credit Suisse Group	Lower Price Target	Neutral	$256.00 ➝ $246.00	N/A	i
11/10/2017	BMO Capital Markets	Boost Price Target	Outperform	$290.00 ➝ $300.00	N/A	i
11/9/2017	Morgan Stanley	Lower Price Target	Overweight	$276.00 ➝ $270.00	N/A	i
11/9/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform ➝ Sector Perform	$245.00 ➝ $242.00	N/A	i
11/2/2017	Credit Suisse Group	Initiated Coverage	Neutral	$256.00	N/A	i
10/16/2017	BMO Capital Markets	Initiated Coverage	Outperform	$300.00	N/A	i
10/13/2017	Jefferies Financial Group	Reiterated Rating	Hold	$257.00	N/A	i
10/10/2017	Royal Bank of Canada	Reiterated Rating	Hold	$245.00	N/A	i
10/9/2017	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$253.00	N/A	i
9/20/2017	Cowen	Reiterated Rating	Outperform	$230.00 ➝ $275.00	Medium	i
8/17/2017	Morgan Stanley	Boost Price Target	Overweight	$269.00 ➝ $276.00	Low	i
8/9/2017	UBS Group	Reiterated Rating	Neutral	$237.00 ➝ $250.00	Low	i
8/7/2017	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$234.00 ➝ $243.00	Low	i
8/4/2017	Jefferies Financial Group	Reiterated Rating	Hold	$257.00	Low	i
8/3/2017	Cantor Fitzgerald	Reiterated Rating	Neutral	$200.00 ➝ $223.00	Low	i Rating by S. Halper at Cantor Fitzgerald
8/3/2017	Oppenheimer	Boost Price Target	Outperform	$236.00 ➝ $255.00	Medium	i
8/3/2017	Credit Suisse Group	Reiterated Rating	Outperform	$250.00 ➝ $260.00	High	i
8/3/2017	Piper Jaffray Companies	Boost Price Target	Overweight	$280.00	High	i
7/14/2017	Piper Jaffray Companies	Reiterated Rating	Buy	$246.00	Low	i
7/14/2017	Cowen	Reiterated Rating	Buy	$230.00	Low	i
7/14/2017	Bank of America	Boost Price Target	Buy	$270.00 ➝ $275.00	Low	i
7/13/2017	Credit Suisse Group	Reiterated Rating	Outperform	$245.00 ➝ $250.00	Low	i
6/28/2017	UBS Group	Reiterated Rating	Neutral	$205.00 ➝ $237.00	N/A	i
6/28/2017	Citigroup	Initiated Coverage	Buy ➝ Buy	$275.00	Medium	i
6/23/2017	Cantor Fitzgerald	Reiterated Rating	Not Available ➝ Neutral		Low	i Rating by S. Halper at Cantor Fitzgerald
6/9/2017	Argus	Upgrade	Hold ➝ Buy	$260.00	Low	i
6/6/2017	Morgan Stanley	Initiated Coverage	Overweight ➝ Overweight	$262.00	Low	i
6/5/2017	Royal Bank of Canada	Reiterated Rating	Hold	$214.00	Low	i
5/30/2017	SVB Leerink	Boost Price Target	Outperform	$250.00 ➝ $265.00	Low	i
5/10/2017	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold	$234.00 ➝ $216.00	Low	i
5/4/2017	Jefferies Financial Group	Reiterated Rating	Hold	$221.00 ➝ $230.00	High	i
4/26/2017	Cantor Fitzgerald	Boost Price Target	Neutral	$190.00 ➝ $200.00	Low	i Rating by J. France at Cantor Fitzgerald
4/25/2017	Evercore ISI	Reiterated Rating	Outperform	$240.00	Low	i
4/25/2017	Cowen	Reiterated Rating	Outperform	$230.00	Low	i
4/21/2017	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$237.00 ➝ $221.00	Low	i
4/5/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$216.00	Low	i
3/30/2017	CIBC	Reiterated Rating	Outperform		Low	i
3/30/2017	Oppenheimer	Initiated Coverage	Outperform ➝ Outperform	$236.00 ➝ $236.00	Low	i
3/24/2017	Jefferies Financial Group	Reiterated Rating	Buy	$237.00	Medium	i
2/27/2017	Evercore ISI	Reiterated Rating	Overweight		N/A	i
2/15/2017	Cantor Fitzgerald	Boost Price Target	Neutral	$186.00 ➝ $190.00	N/A	i Rating by J. France at Cantor Fitzgerald
2/10/2017	Royal Bank of Canada	Reiterated Rating	Hold	$207.00	N/A	i
2/6/2017	Cantor Fitzgerald	Initiated Coverage	Neutral	$186.00	N/A	i Rating by J. France at Cantor Fitzgerald
1/27/2017	Bank of America	Initiated Coverage	Buy		N/A	i
1/24/2017	Stifel Nicolaus	Downgrade	Buy ➝ Hold	$214.00 ➝ $210.00	N/A	i
1/18/2017	Argus	Reiterated Rating	Hold		N/A	i
1/9/2017	Barclays	Reiterated Rating	Hold	$217.00	N/A	i
1/6/2017	Cantor Fitzgerald	Reiterated Rating	Hold	$225.00	N/A	i Rating by J. France at Cantor Fitzgerald
1/3/2017	Piper Jaffray Companies	Initiated Coverage	Overweight	$231.00	N/A	i
12/16/2016	Jefferies Financial Group	Reiterated Rating	Buy	$237.00	N/A	i Rating by David Windley at Jefferies Financial Group Inc.
12/7/2016	Cantor Fitzgerald	Downgrade	Buy ➝ Hold	$225.00	N/A	i Rating by Joseph France at Cantor Fitzgerald
12/4/2016	Susquehanna Bancshares	Reiterated Rating	Neutral	$180.00 ➝ $200.00	N/A	i
12/1/2016	Jefferies Financial Group	Reiterated Rating	Buy	$206.00 ➝ $230.00	N/A	i Rating by David Windley at Jefferies Financial Group Inc.
11/14/2016	UBS Group	Set Price Target	Hold	$194.00	N/A	i Rating by A.J. Rice at UBS Group AG
11/11/2016	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$175.00 ➝ $210.00	N/A	i Rating by Scott Fidel at Credit Suisse Group AG
11/10/2016	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$163.00 ➝ $202.00	N/A	i Rating by Gary Taylor at JPMorgan Chase & Co.
11/8/2016	UBS Group	Reiterated Rating	Neutral	$171.00 ➝ $170.00	N/A	i Rating by a.j. rice at UBS Group AG
11/7/2016	Barclays	Reiterated Rating	Hold	$191.00	N/A	i
11/7/2016	Jefferies Financial Group	Reiterated Rating	Buy	$206.00	N/A	i Rating by David Windley at Jefferies Financial Group Inc.
10/14/2016	Barclays	Reiterated Rating	Equal Weight	$191.00	N/A	i
10/13/2016	Susquehanna Bancshares	Reiterated Rating	Neutral	$180.00	N/A	i
10/13/2016	Royal Bank of Canada	Lower Price Target	Sector Perform	$222.00 ➝ $217.00	N/A	i
9/22/2016	Evercore ISI	Initiated Coverage	Buy	$200.00	N/A	i
9/13/2016	Credit Suisse Group	Reiterated Rating	Hold	$188.00	N/A	i Rating by Scott Fidel at Credit Suisse Group AG
8/31/2016	UBS Group	Reiterated Rating	Hold		N/A	i Rating by A.J. Rice at UBS Group AG
8/23/2016	Argus	Reiterated Rating	Hold		N/A	i
8/22/2016	UBS Group	Reiterated Rating	Hold		N/A	i Rating by A.J. Rice at UBS Group AG
8/16/2016	Credit Suisse Group	Boost Price Target	Neutral	$175.00 ➝ $188.00	N/A	i Rating by Scott Fidel at Credit Suisse Group AG
8/8/2016	Cantor Fitzgerald	Reiterated Rating	Buy		N/A	i Rating by Joseph France at Cantor Fitzgerald
8/4/2016	Jefferies Financial Group	Lower Price Target	Buy	$220.00 ➝ $217.00	N/A	i Rating by David Windley at Jefferies Financial Group Inc.
8/4/2016	Barclays	Lower Price Target	Equal Weight	$193.00 ➝ $191.00	N/A	i
7/25/2016	Jefferies Financial Group	Reiterated Rating	Buy	$210.00 ➝ $220.00	N/A	i Rating by David Windley at Jefferies Financial Group Inc.
7/22/2016	Royal Bank of Canada	Reiterated Rating	Buy	$220.00 ➝ $224.00	N/A	i
7/22/2016	Royal Bank of Canada	Boost Price Target	Outperform	$220.00 ➝ $224.00	N/A	i
7/22/2016	(FBRC)	Lower Price Target	Mkt Perform	$220.00 ➝ $170.00	N/A	i
7/21/2016	Credit Suisse Group	Boost Price Target	Neutral	$160.00 ➝ $170.00	N/A	i Rating by Scott Fidel at Credit Suisse Group AG
7/21/2016	Wolfe Research	Upgrade	Outperform	$192.00	N/A	i
7/18/2016	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$158.89 ➝ $210.00	N/A	i
7/9/2016	Cantor Fitzgerald	Reiterated Rating	Buy		N/A	i Rating by Joseph France at Cantor Fitzgerald
7/8/2016	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$196.00 ➝ $150.00	N/A	i
6/28/2016	Credit Suisse Group	Reiterated Rating	Hold		N/A	i Rating by Scott Fidel at Credit Suisse Group AG
6/28/2016	Wolfe Research	Initiated Coverage	Market Perform	$244.00	N/A	i
6/21/2016	SVB Leerink	Reiterated Rating	Outperform		N/A	i Rating by Ana Gupte at SVB Leerink LLC

(Data available from 6/14/2016 forward)

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.

Today's Range

Now: $419.18

$416.32

$422.10

50 Day Range

MA: $438.12

$407.15

$469.97

52 Week Range

Now: $419.18

$365.06

$475.44

Volume

719,300 shs

Average Volume

983,458 shs

Market Capitalization

$54.08 billion

P/E Ratio

14.91

Dividend Yield

0.67%

Beta

0.88

Frequently Asked Questions

What sell-side analysts currently cover shares of Humana?

The following sell-side analysts have issued reports on Humana in the last twelve months: Argus, Cantor Fitzgerald, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Mizuho, Oppenheimer Holdings Inc., Piper Sandler, Royal Bank of Canada, Sanford C. Bernstein, Smith Barney Citigroup, Stephens, SVB Leerink LLC, Truist, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for HUM.

What is the current price target for Humana?

18 Wall Street analysts have set twelve-month price targets for Humana in the last year. Their average twelve-month price target is $470.22, suggesting a possible upside of 12.2%. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell has the highest price target set, predicting HUM will reach $510.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $410.00 for Humana in the next year.
View the latest price targets for HUM.

What is the current consensus analyst rating for Humana?

Humana currently has 4 hold ratings and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HUM will outperform the market and that investors should add to their positions of Humana.
View the latest ratings for HUM.

What other companies compete with Humana?

Other companies that are similar to Humana include UnitedHealth Group, Anthem, Cigna, Centene, Molina Healthcare, Magellan Health and Triple-S Management.

How do I contact Humana's investor relations team?

Humana's physical mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider's listed phone number is 502-580-1000 and its investor relations email address is [email protected] The official website for Humana is www.humana.com.